Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase ...

UK study suggests that patients with prolactinoma treated with dopamine agonists are more likely to develop impulse control disorders ...

Camurus announces positive results from POSITANO phase 2b study of octreotide SC depot in patients with symptomatic polycystic liver disease: Lund, Sweden Thursday, June 19, 2025, ...

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND ...

Diagnosed with early-stage lung cancer, she is among the first patients in China to receive the LK101 injection – a personalised mRNA vaccine designed to slash the risk of relapse. Lecheng ...

The attack occurred on Bourbon Street during New Year's Day celebrations. A young mother teaching her son to read. A former college football player "on top of the world" living in New York City ...